Treating ‘Maleficents’ AKA…Molluscum Contagiosum

Medically reviewed on 7.15.2024 by the PA/NP EMERGE Advisory Board

Shanna Miranti, MPAS, PA-C, introduces YCANTH, the first FDA-approved treatment for molluscum contagiosum. She details its effective and safe application for patients 2 years and older and emphasizes convenience and predictability, highlighting seamless integration into dermatologic practice as a tool to enhance patient outcomes with its precise, consistent application.